Patents by Inventor Philip Hipskind

Philip Hipskind has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Non-peptide tachykinin receptor antagonists
    Patent number: 5670499
    Abstract: This invention provides a novel series of non-peptidyl compounds which are useful in the treatment or prevention of a physiological disorder associated with an excess of tachykinins. This invention also provides methods for the treatment of such physiological disorders as well as pharmaceutical formulations which employ these novel compounds.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: September 23, 1997
    Assignee: Eli Lilly and Company
    Inventors: Sung Y. Cho, Thomas A. Crowell, Bruce D. Gitter, Philip A. Hipskind, J. Jeffry Howbert, Joseph H. Krushinski, Jr., Karen L. Lobb, Brian S. Muehl, James A. Nixon
  • Pyrrolidinyl tachykinin receptor antagonists
    Patent number: 5607947
    Abstract: This invention provides a novel series of substituted pyrrolidines which are useful in the treatment or prevention of a physiological disorder associated with an excess of tachykinins. This invention also provides methods for the treatment of such physiological disorders as well as pharmaceutical formulations which employ these novel compounds.
    Type: Grant
    Filed: February 21, 1995
    Date of Patent: March 4, 1997
    Assignee: Eli Lilly and Company
    Inventor: Philip A. Hipskind
  • 2-acylaminopropanamides as tachykinin receptor antagonists
    Patent number: 5565568
    Abstract: This invention provides a series of novel substituted propanamides which are useful in the treatment or prevention of a physiological disorder associated with an excess of tachykinins. This invention also provides methods for the treatment of such physiological disorders as well as pharmaceutical formulations which employ these novel compounds.
    Type: Grant
    Filed: April 6, 1995
    Date of Patent: October 15, 1996
    Assignee: Eli Lilly and Company
    Inventors: Sung-Yong S. Cho, Philip A. Hipskind, J. Jeffry Howbert, Brian S. Muehl, James A. Nixon
  • Hexamethyleneiminyl tachykinin receptor antagonists
    Patent number: 5563133
    Abstract: This invention provides a novel series of substituted hexamethyleneimines which are useful in the treatment or prevention of a physiological disorder associated with an excess of tachykinins. This invention also provides methods for the treatment of such physiological disorders as well as pharmaceutical formulations which employ these novel compounds.
    Type: Grant
    Filed: February 21, 1995
    Date of Patent: October 8, 1996
    Assignee: Eli Lilly and Company
    Inventor: Philip A. Hipskind
  • Bis-piperidinyl non-peptidyl neurokinin receptor antagonists
    Patent number: 5530009
    Abstract: This invention provides novel compound of the formula ##STR1## which is neurokinin receptor antagonist.
    Type: Grant
    Filed: June 5, 1996
    Date of Patent: June 25, 1996
    Assignee: Eli Lilly and Company
    Inventors: Sung Yong S. Cho, James D. Copp, Francis O. Ginah, Guy J. Hansen, Philip A. Hipskind, Bret E. Huff, Michael J. Martinelli, Michael A. Staszak, Roger W. Tharp-Taylor